Developer of synthetic medicinal marijuana therapies raises $13M

Zynerba Pharmaceuticals Inc., a specialty pharmaceutical company developing transdermal cannabinoid treatments (aka synthetic marijuana therapies), said Wednesday it has raised $13 million in a private stock sale...